Results 11 to 20 of about 27,421 (247)

Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin‐Deficient Mice

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The biological mechanism of action for osteoprotegerin, a soluble decoy receptor for the receptor activator of nuclear factor‐kappa B ligand in the vascular structure, has not been elucidated.
Toshihiro Tsuruda, Atsushi Yamashita, Misa Otsu, Masanori Koide, Yuko Nakamichi, Yoko Sekita‐Hatakeyama, Kinta Hatakeyama, Taro Funamoto, Etsuo Chosa, Yujiro Asada, Nobuyuki Udagawa, Johji Kato, Kazuo Kitamura   +12 more
doaj   +2 more sources

Value of osteoprotegerin, RANKL, interleukin-17 in mechanisms of bone metabolism disorders [PDF]

Journal of Education, Health and Sport, 2017
The relationship between osteoprotegerin, RANKL and interleukin-17 inthe mechanisms of abnormal remodeling of bone tissue during experimental periodontitis was studied in this work. Increased levels of RANKL and pro-inflammatory IL-17 were found, as well
V. F. Cheremisina
doaj   +4 more sources

Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes

Cardiovascular Diabetology, 2013
Background Osteoprotegerin is a member of the tumor necrosis factor-related family and inhibits RANK stimulation of osteoclast formation as a soluble decoy receptor.
Aoki Atsushi, Murata Miho, Asano Tomoko, Ikoma Aki, Sasaki Masami, Saito Tomoyuki, Otani Taeko, Jinbo Sachimi, Ikeda Nahoko, Kawakami Masanobu, Ishikawa San-e   +10 more
doaj   +2 more sources

Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women – a pilot study

Rheumatology, 2016
Objectives: Osteoprotegerin (OPG) has an important role in bone remodeling, and it has been proposed that the OPG gene might be a candidate gene for osteoporosis predisposition.
Selma Cvijetic, Simeon Grazio, Pasezada Kosovic, Melita Uremovic, Tomislav Nemcic, Jasminka Bobic   +5 more
doaj   +2 more sources

Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function [PDF]

Diagnostics
Introduction: Osteoprotegerin (OPG) is recognized as an emerging biomarker for atherosclerosis. We hypothesized that atherosclerotic lesions localized across multiple vascular beds would result in greater elevations in OPG levels in the blood. Therefore,
Anna Maria Bednarek, Aleksander Jerzy Owczarek, Dominika Dziadosz, Magdalena Olszanecka-Glinianowicz, Jerzy Tadeusz Chudek   +4 more
doaj   +2 more sources

Serum Osteoprotegerin Is Associated Independently with Peripheral Arterial Stiffness in Chronic Kidney Disease [PDF]

Diagnostics
Background/Objectives: Patients with chronic kidney disease (CKD) often present with peripheral arterial stiffness (PAS), which is associated with an increased cardiovascular risk.
Yahn-Bor Chern, Po-Yu Huang, Yu-Hsien Lai, Chih-Hsien Wang, Jen-Pi Tsai, Bang-Gee Hsu   +5 more
doaj   +2 more sources

Osteoprotegerin: regulator, protector and marker

Orvosi Hetilap, 2008
A csontbiológia terén végzett vizsgálatok vezettek a tumornekrózis-faktorok családjába tartozó receptorok, így az osteoprotegerin és a receptor activator of nuclear factor κB (RANK) szerepének tisztázásához a csontátépülés folyamatának szabályozásában.
Taha, El Hadj Othmane, Gábor, Speer, Bertalan, Fekete, Tamás, Szabó, József, Egresits, Erzsébet, Fodor, István, Kiss, János, Nemcsik, András, Szabó, Zsófia, Németh, Miklós, Szathmári, András, Tislér   +11 more
core   +4 more sources

Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study) [PDF]

Kidney Research and Clinical Practice, 2022
Background Osteoprotegerin is an important regulator of bone metabolism and vascular calcification. The association between serum osteoprotegerin level and chronic kidney disease (CKD) progression has not been elucidated.
Tae Ryom Oh, Chana Myeong, Su Hyun Song, Hong Sang Choi, Sang Heon Suh, Chang Seong Kim, Eun Hui Bae, Wookyung Chung, Kyu Hun Choi, Kook Hwan Oh, Seong Kwon Ma, Soo Wan Kim   +11 more
doaj   +1 more source

Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with infection and co-existing inflammatory bowel disease

Journal of International Medical Research, 2021
Objective To investigate the effect of sequential Helicobacter pylori eradication therapy on serum osteoprotegerin levels in patients with H. pylori infection and co-existing inflammatory bowel disease (IBD).
Hussam Murad, Misbahuddin Rafeeq, Mahmoud Mosli, Mamdouh Gari, Mohammed Basheikh   +4 more
doaj   +1 more source

Interactions of porphyromonas gingivalis with bone marrow cells: implications on mediators of bone resorption [PDF]

, 2012
PhDPeriodontitis is a multi-factorial disease characterised by the loss of connective tissue and underlying alveolar bone leading to the loss of teeth. Porphyromonas gingivalis (P.
Reddi, Durga
core   +4 more sources